4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-067430
Chief Technical Officer sold 7,969 shares at an average $77.78 ($619,851)
- Chief Technical Officer acquired 7,969 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-07-09 | Option exercise 10b5-1 | +7,969 | $6.80 | $54,189 | 16,478 | D |
| Shulman Joseph Chief Technical Officer | 2025-07-09 | Sale 10b5-1 | −3,984 | $75.56 | $301,051 | 12,494 | D |
| Shulman Joseph Chief Technical Officer | 2025-07-09 | Sale 10b5-1 | −3,985 | $80.00 | $318,800 | 8,509 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-07-09 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −7,969 | 11,953 | D | ||
| Open-market sales · 7,969 sh · avg $77.78 · $619,851 | |||||||
Loading xslF345X05/tm2520691-3_4seq1.xml…